All articles
How Many mg Is 40 Units of Semaglutide? Syringe Units Explained
Reading time:
9 mins
Weight loss

Label doses from 0.25 mg to 2.4 mg, converted to units
Going the other way, here’s how many units the FDA-labeled semaglutide doses would take at the same example concentrations. It covers questions like how many units is .25 mg of semaglutide, how many units is 1 mg of semaglutide, and how many units of semaglutide is 2.4 mg (1,3,4).
Concentration differs between pharmacies and vials. Always follow your own provider’s instructions and your vial label, and ask your pharmacist or provider if your units don’t match.
Dose in mg | Example vial: 1 mg/mL | Example vial: 2.5 mg/mL | Example vial: 5 mg/mL |
0.25 mg | 0.25 mL = 25 units | 0.1 mL = 10 units | 0.05 mL = 5 units |
0.5 mg | 0.5 mL = 50 units | 0.2 mL = 20 units | 0.1 mL = 10 units |
1 mg | 1 mL = 100 units | 0.4 mL = 40 units | 0.2 mL = 20 units |
1.7 mg | 1.7 mL = 170 units | 0.68 mL = 68 units | 0.34 mL = 34 units |
2 mg | 2 mL = 200 units | 0.8 mL = 80 units | 0.4 mL = 40 units |
2.4 mg | 2.4 mL = 240 units | 0.96 mL = 96 units | 0.48 mL = 48 units |
These are branded label doses used only as math examples. They aren’t a dosing schedule for compounded semaglutide, and your provider sets your dose.
So how many units is 0.5 mg of semaglutide? Anywhere from 10 to 50 units in this chart. How many units is 2mg of semaglutide? Between 40 and 200. And how many units is 2.4 mg of semaglutide? Between 48 and 240.
Now look at the first column. Anything past 100 units won’t fit in a standard 1 mL syringe, because that barrel holds 100 units (1). If your math lands there, stop and call your pharmacist or provider.
Wegovy and Ozempic pens are set in milligrams, not units
If you use a branded pen, you don’t count units at all. Wegovy comes in single-dose pens and syringes at fixed strengths, and Ozempic comes in pens that deliver set milligram doses (3,4). The units question only applies to vials drawn with an insulin syringe.
Wegovy’s label, revised in June 2026, lists four-week steps of 0.25 mg, 0.5 mg, 1 mg, and 1.7 mg weekly. After that, adults on it for weight reduction take a maintenance dose of 1.7 mg or 2.4 mg (3). It also allows a maximum of 7.2 mg after at least four weeks at 2.4 mg, if more weight reduction is clinically indicated (3). The Wegovy dosage guide covers that schedule in more depth.
Ozempic is approved for adults with type 2 diabetes, not for weight loss. Its label starts at 0.25 mg weekly and steps up to 0.5 mg, 1 mg, and a maximum of 2 mg (4).
Even branded products don’t share one concentration. Ozempic’s three pens hold about 0.68, 1.34, and 2.68 mg per mL, while a 1 mg Wegovy dose comes in 0.5 mL and a 2.4 mg dose in 0.75 mL (3,4). One drug, several concentrations.
Small unit mix-ups have caused 10-fold overdoses
Dosing errors with compounded semaglutide are documented, not hypothetical. FDA reported in July 2024 that some patients gave themselves five to 20 times the intended dose (2). In several cases, people told to draw 5 units, or 0.05 mL, drew 50 units instead (2).
Some errors started before the vial reached home. FDA also received reports of health care providers miscalculating when converting milligrams to units or milliliters, leading to doses five to 10 times too high (2). Reported effects included nausea, vomiting, abdominal pain, fainting, dehydration, acute pancreatitis, and gallstones, and some people were hospitalized (2). For comparison, here’s which GLP-1 side effects are common and which need care.
A 2023 case series from a regional poison control center described three people who used semaglutide from compounding pharmacies and an aesthetic spa (6). Two gave themselves 10-fold doses. All three had nausea, vomiting, and abdominal pain, mostly lasting days. One got a vial and syringes with no pharmacist counseling, and one dosed in milliliters and units rather than milligrams (6).
The authors pointed to a design gap. Compounded vials don’t use the safety features of prefilled pens, which they said allows for large overdoses (6).
Five checks before you draw a dose
A short routine can help you catch a mix-up before the needle goes in. FDA advises talking with your provider or compounder about how to measure your intended dose, and says compounders should give you the right syringe size for it (2). These five checks put that advice into practice.
Find the mg/mL on your vial label and match it to the mg/mL on your written instructions.
Confirm your syringe is marked for U-100 insulin and that its barrel holds your full number of units (1).
Work the formula yourself, then compare your result with the units your instructions list.
Recheck everything when a new vial arrives, since compounded products can vary in concentration (2).
Use a new, sterile needle and syringe for every dose, and follow FDA’s general advice to use a multi-dose vial within 28 days of first use (5).
If any number doesn’t match, don’t inject. Call your pharmacist or provider first. If you’re unsure where a vial came from, learn how to spot fake semaglutide. And any change to your dose belongs to your provider, not to the math.
Compounded semaglutide is not an FDA-approved product
Compounded semaglutide is made by a pharmacy rather than sold as a branded, FDA-approved drug. FDA states that compounded drugs are not FDA-approved and that it does not review them for safety, effectiveness, or quality before they’re marketed (5). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. More background sits in this summary of FDA guidance on compounding.
Safety rules start with the drug itself. The Wegovy label says not to use semaglutide if you or a family member has had medullary thyroid carcinoma (MTC), or if you have MEN 2, a rare inherited gland condition (3). Wegovy and Ozempic carry a boxed warning for risk of thyroid C-cell tumors, which a provider will discuss with you (3,4). A prior serious allergic reaction to semaglutide or any ingredient in the product is also a contraindication (3). A provider reviews these with you before any prescription.
If you’re exploring semaglutide for weight loss, you can check your eligibility through Mochi Health. Affiliated Mochi Medical providers decide whether a medication is appropriate for you, and they’re the right people to ask about your dose.
The bottom line
Forty units of semaglutide is always 0.4 mL on a U-100 syringe. How many mg that holds depends on your vial: 0.4 mg, 1 mg, or 2 mg at the three example concentrations here (1). Your vial’s mg/mL is the number that turns units into milligrams.
Keep the formula handy. Recheck it with every new vial, and bring any mismatch to your pharmacist or provider. Concentration differs between pharmacies and vials, so always follow your own provider’s instructions and your vial label.
Want to see whether semaglutide treatment could be an option for you? Check your eligibility through Mochi Health, and a licensed provider will decide whether treatment is appropriate.
Frequently asked questions
How many mg is 50 units of semaglutide?
Fifty units is 0.5 mL on a U-100 syringe. That’s 0.5 mg at an example 1 mg/mL, 1.25 mg at 2.5 mg/mL, and 2.5 mg at 5 mg/mL (1). Check the mg/mL on your own vial label before you rely on any of those numbers.
How many units is 0.25 mg of semaglutide?
At example concentrations, 0.25 mg is 25 units at 1 mg/mL, 10 units at 2.5 mg/mL, and 5 units at 5 mg/mL (1). Small volumes like 5 units are where FDA saw people draw 50 by mistake, so read the syringe line slowly (2).
Is 40 units of semaglutide a lot?
It depends entirely on concentration. Forty units could be 0.4 mg or 2 mg in the examples here (1). Only your provider’s prescription and your vial label can tell you whether 40 units matches your dose.
Do Ozempic and Wegovy pens use units?
No. Branded pens deliver set milligram doses, so there’s nothing to convert (3,4). Units only come up when you draw from a vial with an insulin syringe.
What happens if you miss a dose?
MedlinePlus advises against taking a double dose to make up for a missed one, and the time window for a late dose depends on why you take semaglutide (7). Ask your provider which window applies to you.
References
MedlinePlus Medical Encyclopedia. Giving an insulin injection. National Library of Medicine. Accessed November 19, 2026. MedlinePlus insulin injection
US Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. FDA dosing errors alert
Novo Nordisk. WEGOVY (semaglutide) injection, for subcutaneous use. Prescribing information. DailyMed, National Library of Medicine. Revised June 2026. Wegovy label
Novo Nordisk. OZEMPIC (semaglutide) injection, for subcutaneous use. Prescribing information. DailyMed, National Library of Medicine. Revised May 2026.
US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Content current as of October 1, 2026.
Lambson JE, Flegal SC, Johnson AR. Administration errors of compounded semaglutide reported to a poison control center: case series. J Am Pharm Assoc (2003). 2023;63(5):1643-1645. PMID: 37392810.
MedlinePlus Drug Information. Semaglutide injection. National Library of Medicine. Last revised May 15, 2026.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Compounded semaglutide, Wegovy, and Ozempic require a written prescription from a licensed provider. Speak with a provider to determine if compounded semaglutide, Wegovy, or Ozempic is appropriate for you. Wegovy is FDA-approved, with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction in certain adults and children 12 years and older with obesity and certain adults with overweight, and for other uses described in its label. Ozempic is FDA-approved, with diet and exercise, to improve blood sugar control in adults with type 2 diabetes, and to reduce certain heart and kidney risks in adults with type 2 diabetes. Wegovy and Ozempic carry a boxed warning for risk of thyroid C-cell tumors that a provider will discuss with you. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.
Share this post
Weight loss
More articles





